Notícias Eulerpool Cytokinetics

Cytokinetics Eulerpool-AFX

Cytokinetics Notícias de ações

Cytokinetics é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Cytokinetics nós reunimos aqui.

• 10 de julho ·

  Yahoo
  Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
• 2 de julho ·

  Yahoo
  Insider Sale: Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK)
• 26 de junho ·

  GuruFocus
  Insider Sale at Cytokinetics Inc (CYTK): EVP Research & Development Fady Malik Sells Shares
• 26 de junho ·

  InvestorPlace
  7 Biotech Stocks to Boost Your Portfolio to Peak Health
• 24 de junho ·

  TipRanks
  Buy Rating Affirmed: Cytokinetics’ Aficamten Shows Strong Commercial Promise in oHCM Treatment
• 24 de junho ·

  Thefly.com
  Cytokinetics price target lowered by $12 at JPMorgan, here's why
• 18 de junho ·

  Yahoo
  Insider Selling: Director B Parshall Sells Shares of Cytokinetics Inc (CYTK)
• 17 de junho ·

  Yahoo
  Cytokinetics Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
• 17 de junho ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Cytokinetics (CYTK) and Gossamer Bio (GOSS)
• 17 de junho ·

  Thefly.com
  Cytokinetics initiates Phase 1 study of aficamten